Financial Instruments Financial Instruments (Tables)
|6 Months Ended|
Jul. 03, 2021
|Derivative Instruments and Hedging Activities Disclosure [Abstract]|
|Fair Values of Derivative Instruments||
As of July 3, 2021, December 31, 2020 and June 27, 2020, the fair values of the Company's derivative instruments were:
As of July 3, 2021, December 31, 2020 and June 27, 2020, asset derivatives are included within Prepaid expenses and other, and Other long-term assets and liability derivatives are included within Accrued expenses and Other long-term liabilities in the Condensed Consolidated Balance Sheets.
|Effect of Derivative Instruments on the Condensed Consolidated Statements of Comprehensive Income||
The effect of derivative instruments on the Condensed Consolidated Statements of Comprehensive Income for the three and six months ended July 3, 2021 and June 27, 2020 is as shown in the tables below.
The amount of gain (loss) on derivatives recognized in Accumulated other comprehensive loss was as follows:
The amount of gain (loss) reclassified from Accumulated other comprehensive loss into earnings was as follows:
No definition available.
Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef